One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00192-1
Volume 21, Issue 5, May 2023, Pages A11-A12
Successful Endoscopic Closure of Gastrobronchial Fistula Using Polyglycolic Acid Sheets with Fibrin Glue
Yoshiaki Ando, Takeshi Setoyama, and Hiroyuki Marusawa
doi : 10.1016/j.cgh.2022.10.013
Volume 21, Issue 5, May 2023, Page A15
Ménétrier Disease: A Rare Cause of Iron Deficiency Anemia
Wissam Kiwan, 1 Yuna Gong, 2 and James Buxbaum
doi : 10.1016/j.cgh.2022.10.019
Volume 21, Issue 5, May 2023, Page A18
Wandering Spleen: An Unusual Cause of Recurrent Abdominal Pain
Oscar Borsani, 1,2 Marta Braschi-Amirfarzan, 3 Emanuela Boveri, 4 and Elisa Rumi
doi : 10.1016/j.cgh.2022.11.003
Volume 21, Issue 5, May 2023, Pages A19-A20
Blue Notes
CHARLES J. KAHI, MD, MS, AGAF
doi : 10.1016/j.cgh.2023.02.009
Volume 21, Issue 5, May 2023, Pages 1125-1126
A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals
KIRA L. NEWMANVICTOR G. CHEDID
doi : 10.1016/j.cgh.2023.02.006
Volume 21, Issue 5, May 2023, Pages 1127-1133
Designing the Endoscopy Lab to Optimize Training
MALORIE SIMONSCHANDNI PATTNISAMIR C. GROVERTYLER M. BERZIN
doi : 10.1016/j.cgh.2022.11.041
Volume 21, Issue 5, May 2023, Pages 1134-1137
Cultivating Cultural Competency in Gastroenterology Practices
Cristina Fernandez, 1, * Nelson Bean, 1, * and Renee Williams
doi : 10.1016/j.cgh.2022.12.022
Volume 21, Issue 5, May 2023, Pages 1138-1140
AGA Clinical Practice Update on Role of EUS-Guided Gallbladder Drainage in Acute Cholecystitis: Commentary
Shayan S. Irani, 1 Kaveh Sharzehi, 2 and Uzma D. Siddiqui 3
doi : 10.1016/j.cgh.2022.12.039
Volume 21, Issue 5, May 2023, Pages 1141-1147
How to Manage Targeted Immune Suppressants (Biologics and Oral Small-molecule Drugs) Perioperatively for Inflammatory Bowel Disease and non-Inflammatory Bowel Disease surgery
Benjamin L. Cohen, 1 Eddy Lincango, 2 and Stefan D. Holubar
doi : 10.1016/j.cgh.2023.01.042
Volume 21, Issue 5, May 2023, Pages 1148-1151.e1
A Revisit of the Natural History of Nonalcoholic Fatty Liver Disease
MAZEN NOUREDDIN, MD, MHScVINCENT WAI-SUN WONG, MD
doi : 10.1016/j.cgh.2022.08.019
Volume 21, Issue 5, May 2023, Pages 1152-1153
Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies
Phuc Le, 1 Julia Yang Payne, 1,2 Lu Zhang, 3 Abhishek Deshpande, 1 Michael B. Rothberg, 1 Naim Alkhouri, 4 William Herman, 5,6 Adrian V. Hernandez, 7,8 Mary Schleicher, 9 Wen Ye, 10 and Srinivasan Dasarathy
doi : 10.1016/j.cgh.2022.07.033
Volume 21, Issue 5, May 2023, Pages 1154-1168
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis
Daniel Q. Huang, 1,2,3, * Darren J. H. Tan, 2, * Cheng Han Ng, 2 Maral Amangurbanova, 1 Nancy Sutter, 1 Phoebe Wen Lin Tay, 2 Wen Hui Lim, 2 Jie Ning Yong, 2 Ansel Tang, 2 Nicholas Syn, 2 Mark D. Muthiah, 2,3 Eunice X. X. Tan, 2,3 Shravan Dave, 1 Benjamin Tay, 3 Abdul M. Majzoub, 4 Danielle Gerberi, 5 Beom Kyung Kim, 1,6,7 and Rohit Loomba
doi : 10.1016/j.cgh.2022.06.032
Volume 21, Issue 5, May 2023, Pages 1169-1177
Development and Validation of a National US Achalasia Cohort: The Veterans Affairs Achalasia Cohort (VA-AC)
Eric E. Low, 1,2 Rena Yadlapati, 2 Lin Liu, 1,3 Ranier Bustamante, 1 and Samir Gupta
doi : 10.1016/j.cgh.2022.08.030
Volume 21, Issue 5, May 2023, Pages 1178-1187.e1
Esophageal Distensibility Defines Fibrostenotic Severity in Pediatric Eosinophilic Esophagitis
Natalie V. Hoffmann, Kaitlin Keeley, and Joshua B. Wechsler
doi : 10.1016/j.cgh.2022.08.044
Volume 21, Issue 5, May 2023, Pages 1188-1197.e4
Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett’s Esophagus
Theresa Nguyen Wenker, 1,2 Yamini Natarajan, 1 Kadon Caskey, 1 Francisco Novoa, 1 Nabil Mansour, 1 Huy Anh Pham, 3 Jason K. Hou, 1,2 Hashem B. El-Serag, 1,2 and Aaron P. Thrift
doi : 10.1016/j.cgh.2022.09.005
Volume 21, Issue 5, May 2023, Pages 1198-1204
Interval Advanced Gastric Cancer After Negative Endoscopy
Tae Jun Kim, 1, * Jeung Hui Pyo, 2, * Young Hye Byun, 2 Sung Chul Choi, 2 Jin Pyo Hong, 2 Yang Won Min, 1 Hyuk Lee, 1 Byung-Hoon Min, 1 Poong-Lyul Rhee, 1 Jae J. Kim, 1 and Jun Haeng Lee
doi : 10.1016/j.cgh.2022.08.027
Volume 21, Issue 5, May 2023, Pages 1205-1213.e2
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis
Nikhil R. Thiruvengadam, 1,2,3 Douglas E. Schaubel, 4 Kimberly Forde, 5 Peter Lee, 6 Monica Saumoy, 7 and Michael L. Kochman
doi : 10.1016/j.cgh.2022.05.017
Volume 21, Issue 5, May 2023, Pages 1214-1222.e14
Bile Duct Colonization With Enterococcus sp. Associates With Disease Progression in Primary Sclerosing Cholangitis
Ehud Zigmond, 1,2 Britta Franziska Zecher, 3 Anna-Lena Bartels, 3 Tomer Ziv-Baran, 2 Thomas Rösch, 4 Guido Schachschal, 4 Ansgar W. Lohse, 3 Hanno Ehlken, 3,4 and Christoph Schramm
doi : 10.1016/j.cgh.2022.09.006
Volume 21, Issue 5, May 2023, Pages 1223-1232.e3
A Prospective Cohort Study Evaluating PAN-PROMISE, a Patient-reported Outcome Measure to Detect Post-ERCP Morbidity
Nikhil R. Thiruvengadam, 1,2,3 Abdul Kouanda, 4 Anita Kalluri, 2 Douglas Schaubel, 5 Monica Saumoy, 6 Kimberly Forde, 7 Jun Song, 8 Alec Faggen, 4 Brenton G. Davis, 4 Kenechukwu Chudy Onwugaje, 2 Gregory Cote, 9 Mustafa A. Arain, 4,10 and Michael L. Kochman
doi : 10.1016/j.cgh.2022.08.034
Volume 21, Issue 5, May 2023, Pages 1233-1242.e14
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier,* ,‡ Clémence M. Canivet,* ,‡ Charlotte Costentin, §,jj Adrien Lannes,* ,‡ Adèle Delamarre, ¶ Nathalie Sturm, # Brigitte Le Bail,** Sophie Michalak,‡,‡‡ Frédéric Oberti,* ,‡ Marie-Noelle Hilleret, § Marie Irles-Depé, ¶ Isabelle Fouchard,* ,‡ Paul Hermabessiere, ¶ Justine Barthelon, § Paul Calès,*,‡ Bertrand Cariou, §§ Victor de Ledinghen, ¶ and Marine Roux
doi : 10.1016/j.cgh.2022.02.059
Volume 21, Issue 5, May 2023, Pages 1243-1251.e12
The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting
Aaron P. Thrift, 1,2 Theresa H. Nguyen, 3,4 Codey Pham, 5 Maya Balakrishnan, 3 Fasiha Kanwal, 3,4 Rohit Loomba, 6,7 Hao T. Duong, 8 David Ramsey, 4,8 and Hashem B. El-Serag
doi : 10.1016/j.cgh.2022.05.046
Volume 21, Issue 5, May 2023, Pages 1252-1260.e5
Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
Kimberly P. Newton, 1,2 Laura A. Wilson, 3,4 Nancy A. Crimmins, 5,6 Mark H. Fishbein, 7 Jean P. Molleston, 8 Stavra A. Xanthakos, 6,9 Cynthia Behling, 10 and Jeffrey B. Schwimmer, 1,2 for the Nonalcoholic Steatohepatitis Clinical Research Network
doi : 10.1016/j.cgh.2022.05.028
Volume 21, Issue 5, May 2023, Pages 1261-1270
Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study
Axel Wester, 1 Nelson Ndegwa, 2,3,4 and Hannes Hagström
doi : 10.1016/j.cgh.2022.05.048
Volume 21, Issue 5, May 2023, Pages 1271-1280.e7
Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States
Nikita Sandeep Wagle, 1,2 Sulki Park, 1,3 David Washburn, 1,2 Robert L. Ohsfeldt, 1,2 Nicole E. Rich, 4 Amit G. Singal, 4, * and Hye-Chung Kum
doi : 10.1016/j.cgh.2022.07.031
Volume 21, Issue 5, May 2023, Pages 1281-1292.e10
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD
Grazia Pennisi, 1, * Marco Enea, 1, * Alessandra Pandolfo, 1 Ciro Celsa, 1 Michela Antonucci, 2 Carlo Ciccioli, 1 Giuseppe Infantino, 1 Claudia La Mantia, 1 Stefanie Parisi, 1 Adele Tulone, 1 Vito Di Marco, 1 Antonio Craxì, 1 Calogero Cammà , 1 and Salvatore Petta
doi : 10.1016/j.cgh.2022.06.013
Volume 21, Issue 5, May 2023, Pages 1293-1302.e5
Serum HBcrAg and Hepatocellular Carcinoma in a Taiwanese Population Seronegative for HBsAg and Anti-HCV
Yi-Chung Hsieh, 1,5,6 Mei-Hung Pan, 2 Wen-Juei Jeng, 1,5,6 Hui-Han Hu, 2 Jessica Liu, 2,3,7 Masashi Mizokami, 4 Chien-Jen Chen,2 and Hwai-I Yang
doi : 10.1016/j.cgh.2022.06.018
Volume 21, Issue 5, May 2023, Pages 1303-1313.e11
Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas
Abiodun O. Oluyomi, 1,2,3 Hashem B. El-Serag, 2,4,5,6 Adegboyega Olayode, 7 and Aaron P. Thrift
doi : 10.1016/j.cgh.2022.06.031
Volume 21, Issue 5, May 2023, Pages 1314-1322.e5
Texas has the highest hepatocellular carcinoma (HCC) incidence rates in the continental United States, but these rates vary by race-ethnicity. We examined racial-ethnic disparities through a geospatial analysis of the social determinants of health.
ATP7B Genotype and Chronic Liver Disease Treatment Outcomes in Wilson Disease: Worse Survival With Loss-of-Function Variants
Jeremy S. Nayagam, 1,2 Rebecca Jeyaraj, 1 Pierre Foskett, 1 Anil Dhawan,1,3 Aftab Ala, 1,4,5 Deepak Joshi, 1 Adrian Bomford, 1 and Richard J. Thompson
doi : 10.1016/j.cgh.2022.08.041
Volume 21, Issue 5, May 2023, Pages 1323-1329.e4
Although a good genotype-phenotype correlation has not been established in Wilson disease (WD), patients with loss-of-function (LOF) ATP7B variants demonstrate different clinical and biochemical characteristics. We aim to describe long-term treatment outcomes in the chronic liver disease (CLD) phenotype and evaluate an association with LOF variants.
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Byron P. Vaughn, 1,§ Monika Fischer, 2 Colleen R. Kelly, 3 Jessica R. Allegretti, 4 Carolyn Graiziger, 1 Juana Thomas, 3 Emma McClure, 4 Amanda J. Kabage, 1 and Alexander Khoruts
doi : 10.1016/j.cgh.2022.09.008
Volume 21, Issue 5, May 2023, Pages 1330-1337.e2
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis
Kaitlin G. Whaley, 1,2 Ye Xiong, 3 Rebekah Karns, 1 Jeffrey S. Hyams, 4 Subra Kugathasan, 5 Brendan M. Boyle, 6 Thomas D. Walters, 7 Judith Kelsen, 8 Neal LeLeiko, 9 Jason Shapiro, 10 Amanda Waddell, 1 Sejal Fox, 1 Ramona Bezold, 1 Stephanie Bruns, 1 Robin Widing, 12 Yael Haberman, 1,2,13 Margaret H. Collins, 2,11 Tomoyuki Mizuno, 2,3 Phillip Minar, 1,2 Geert R. D’Haens, 14 Lee A. Denson, 1,2 Alexander A. Vinks, 2,3 and Michael J. Rosen 1,
doi : 10.1016/j.cgh.2022.08.016
Volume 21, Issue 5, May 2023, Pages 1338-1347
Net Remission Rates with Biologic Treatment in Crohn’s Disease: A Reappraisal of the Clinical Trial Data
MAIA KAYALRYAN C. UNGAROGEOFFREY BADERJEAN-FREDERIC COLOMBELWILLIAM J. SANDBORNCARLOS STALGIS
doi : 10.1016/j.cgh.2022.02.044
Volume 21, Issue 5, May 2023, Pages 1348-1350
Correlation of LI-RADS 3 or 4 Observations with Histopathologic Diagnosis in Patients with Cirrhosis
COLIN DUNNBO LINNICOLE E. RICHMADHUKAR S. PATELPURVA GOPALAMIT G. SINGAL
doi : 10.1016/j.cgh.2022.03.009
Volume 21, Issue 5, May 2023, Pages 1351-1353.e2
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis
PAULINE VEYRARDGAUTHIER PELLETDAVID LAHARIEMARIA NACHURYPASCAL JUILLERATXAVIER ROBLIN
doi : 10.1016/j.cgh.2022.03.008
Volume 21, Issue 5, May 2023, Pages 1354-1355.e2
The Occurrence of Gastritis in Microscopic Colitis and Inflammatory Bowel Disease
AMNON SONNENBERGKEVIN O. TURNERHOSSEIN SABOORIANANURADHA SINGHALROBERT M. GENTA
doi : 10.1016/j.cgh.2022.03.019
Volume 21, Issue 5, May 2023, Pages 1356-1358.e2
Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects
YING SHANGHANNES HAGSTRÖM
doi : 10.1016/j.cgh.2022.03.020
Volume 21, Issue 5, May 2023, Pages 1359-1361.e2
Comparable Survival for Hepatitis C–Related Hepatocellular Carcinoma After Liver Transplantation Irrespective of Viremic Status
PETER LYMBEROPOULOSANJIYA SHAIKHNICOLE E. RICHJIHANE N. BENHAMMOUFASIHA KANWALGEORGE CHOLANKERIL
doi : 10.1016/j.cgh.2022.03.021
Volume 21, Issue 5, May 2023, Pages 1362-1364.e1
Trends in the Incidence of Upper Gastrointestinal Cancers Show Changing Dynamics
SHRIA KUMARTRACY E. CRANEDAVID S. GOLDBERG
doi : 10.1016/j.cgh.2022.03.034
Volume 21, Issue 5, May 2023, Pages 1365-1367.e1
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy
inFABIENNE CHARBIT-HENRIONMANON HAASSTANISLAS CHAUSSADE*CHRISTOPHE CELLIERNADINE CERF-BENSUSSANGEORGIA MALAMUT
doi : 10.1016/j.cgh.2022.07.030
Volume 21, Issue 5, May 2023, Pages 1368-1371.e2
Exam 1: Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies
doi : 10.1016/j.cgh.2023.02.007
Volume 21, Issue 5, May 2023, Pages e22-e23
Comparative Effectiveness Research to Position Therapies in Ulcerative Colitis: How Fair Are the Comparisons?
DAHHAM ALSOUD, MDBRAM VERSTOCKT, MD, PhDSÉVERINE VERMEIRE, MD, PhD
doi : 10.1016/j.cgh.2022.06.017
Volume 21, Issue 5, May 2023, Pages 1372-1373
Reply
TESSA STRAATMIJER, MD, PhDANDREA E. VAN DER MEULEN, MD, PhDMARJOLIJN DUIJVESTEIN, MD, PhD
doi : 10.1016/j.cgh.2022.07.040
Volume 21, Issue 5, May 2023, Pages 1373-1374
Over-the-Scope Clip in the Management of Nonvariceal UGI Bleeding
JACQUELINE N. CHU, MDJOSEPH C. YARZE, MD
doi : 10.1016/j.cgh.2022.01.017
Volume 21, Issue 5, May 2023, Pages 1374-1375
Reply
FNU CHESTA, MBBSNAVTEJ S. BUTTAR, MD
doi : 10.1016/j.cgh.2022.07.036
Volume 21, Issue 5, May 2023, Pages 1375-1376
Appendectomy and Future Risk of Microscopic Colitis: Correlation or Causation?
CONG DAI, MD, PHDMIN JIANG, MDYU-HONG HUANG, MD
doi : 10.1016/j.cgh.2022.07.021
Volume 21, Issue 5, May 2023, Pages 1376-1377
Reply
JOHN MARET-OUDA, MD, PhD
doi : 10.1016/j.cgh.2022.08.010
Volume 21, Issue 5, May 2023, Page 1377
Sleeping on the Right Side After Esophagectomy
MARCO SOZZI, MDSTEFANO SIBONI, MDLUIGI BONAVINA, MD, FACS
doi : 10.1016/j.cgh.2022.04.030
Volume 21, Issue 5, May 2023, Pages 1377-1378
Fibromuscular Expansion in Crohn’s Disease Ileal Strictures: An Open Issue
HELENA TAVARES DE SOUSA, MDIRENE GULLO, MD, PhD
doi : 10.1016/j.cgh.2022.06.023
Volume 21, Issue 5, May 2023, Pages 1378-1380
Distinct Relapse Patterns Between HBeAg-Negative Patients Stopping Tenofovir and Entecavir
YEN-CHUN LIU, MDYUN-FAN LIAW, MD
doi : 10.1016/j.cgh.2022.08.009
Volume 21, Issue 5, May 2023, Page 1380
